Canadian pot producer Aphria on Tuesday said it would begin trading on the New York Stock Exchange on Friday under the ticker "APHA," as other U.S.-listed marijuana stocks rebounded despite Canada's recreational weed shortages.

"Listing on the NYSE provides Aphria with access to the largest equity market in the world, with increased exposure to a vast array of U.S. institutional and retail investors," CEO Vic Neufeld said in a statement. He added: "We are excited to usher in a new era with the recent legalization of adult-use cannabis in Canada and as we aim to further expand our footing in exciting markets such as Latin America, the Caribbean and Europe."

Big things are happening with the marijuana industry in 2018. Since the beginning of the year:

The pullback in the share prices of Canadian marijuana stocks is giving some recent investors bad dreams.

Those who sat on the sidelines and missed the rally in the past year, however, are looking at the dip in the top cannabis companies and wondering which pot stocks might be attractive picks.

Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) to see if it deserves to be in your portfolio today.

Atlanta, GA-based beverage giant Coca Cola Co. (KO) currently has no plans to enter the cannabis industry with marijuana-infused beverages, the company announced during its recent quarterly earnings call on Tuesday morning. 

Driven by a craze that is assuming almost cult-like proportions, money is pouring into the sectors of the cannabis industry that are focused on cannabidiol (CBD) products.

U.S. pot companies are pushing north of the border in search of capital.

Curaleaf Inc., a Massachusetts-based company backed by Moscow banking veteran Boris Jordan with roughly 30 pot stores open in 12 states, is raising US$350 million through a private placement that values the company at about US$4 billion.

The stock is set to start trading Monday in Canada through a reverse takeover on the CSE and will be one of the most valuable U.S. pot companies.

We think there is going to be huge consolidation — we're going to move very quickly

Moscow banking veteran Boris Jordan

Before the last federal election, the idea of openly growing pot in a field would have been dismissed as reefer madness — and illegal, too. But the Liberals won that contest, formed government, and their campaign promise to legalize recreational marijuana came to fruition this month.

The legislation has also spawned the first proposed (and legal) outdoor cannabis farm in the Ottawa Valley.

Mark Spear, a 34-year-old Ottawa native who has worked in the cannabis industry since 2014, wants to convert a 225-acre former horse and haymaking farm near Burnstown, southeast of Renfrew, into a “canna-tourism” complex that would grow more than 100,000 cannabis plants by 2020, run workshops on how to grow and cook with marijuana, and allow visitors to relax at a pot-friendly spa.

It's fair to say that Hexo Corp.'s (NASDAQOTH:HYYDF) fiscal year 2019, which started on Aug. 1, is already the most exciting year ever for the Canadian marijuana grower. Hexo landed a major partnership with Molson Coors Brewing (NYSE:TAP). The company changed its name from Hydropothecary to Hexo. And it began shipping products to serve Canada's recreational marijuana market.

It's easy to forget during turbulent markets that over the long haul, stocks have helped long-term investors create life-changing wealth. Even just using index funds, disciplined investors who've put money to work regularly in the stock market have seen their savings climb dramatically. Those who've identified promising niches of the market have done far better.

Canadian pot stocks have been hitting the skids ever since the adult-use recreational market opened up on Oct. 17. This marked sell-off, though, may have finally created some compelling long-term bargains. OrganiGram Holdings (NASDAQOTH:OGRMF) and Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB), for instance, have both seen their shares slide in a significant way over the last two weeks of trading. As both of these pot companies are well positioned to become top players in this red-hot industry, though, it might be a good time to consider which of these stocks is the better buy.